tolbutamide has been researched along with Heart Failure in 10 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, C | 1 |
| Gislason, GH | 1 |
| Jørgensen, CH | 1 |
| Hansen, PR | 1 |
| Vaag, A | 1 |
| Sørensen, R | 1 |
| Mérie, C | 1 |
| Olesen, JB | 1 |
| Weeke, P | 1 |
| Schmiegelow, M | 1 |
| Norgaard, ML | 1 |
| Køber, L | 1 |
| Torp-Pedersen, C | 1 |
| MOORE, MJ | 1 |
| Bunnag, SC | 1 |
| Bunnag, S | 1 |
| Nelius, D | 1 |
| Fidel, J | 1 |
| Nelken, L | 1 |
| Saxton, C | 2 |
| Majid, PA | 3 |
| Clough, G | 1 |
| Taylor, SH | 3 |
| Ziegelasch, HJ | 1 |
| Scotti, G | 1 |
| Gatti, A | 1 |
| Di Gregorio, D | 1 |
| Sharma, B | 2 |
| Pakrashi, BC | 1 |
| Dykes, JR | 2 |
10 other studies available for tolbutamide and Heart Failure
| Article | Year |
|---|---|
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Female; Glipizide; Glyburide; Heart Failure; Humans; Hyp | 2011 |
Renal toxicity with nephrotic-like edema resulting from tolbutamide.
Topics: Edema; Edetic Acid; Heart Failure; Tolbutamide | 1962 |
Tolbutamide, postnatal neogenesis of the islets of Langerhans and myocardial insufficiency: a case report.
Topics: Aged; Coronary Disease; Diabetes Complications; Female; Heart Failure; Humans; Hyperplasia; Islets o | 1976 |
[Changes in anticoagulant tolerance. II. Effects of cardiac insufficiency and drugs administered for its therapy].
Topics: Anti-Arrhythmia Agents; Anticoagulants; Antihypertensive Agents; Diuretics; Drug Interactions; Drug | 1974 |
Fatal vascular complications in diabetic patients treated by diet, sulfonylureas and insulin. A retrospective study.
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Chlorpropamide; Diabet | 1974 |
Effect of ouabain on insulin secretion in man.
Topics: Adult; Blood Glucose; Catecholamines; Heart Failure; Humans; Injections, Intravenous; Insulin; Insul | 1972 |
[Extreme hypoglycemia during combined tolbutamide, n-1-butylbiguanide hydrochloride and chloramphenicol therapy].
Topics: Age Factors; Aged; Biguanides; Chloramphenicol; Diabetes Mellitus; Diabetic Angiopathies; Diabetic N | 1972 |
[Ethacrynic acid and carbohydrate metabolism in advanced age].
Topics: Age Factors; Aged; Blood Glucose; Carbohydrate Metabolism; Diabetes Complications; Diabetes Mellitus | 1969 |
Insulin secretion in heart failure.
Topics: Adult; Blood Glucose; Carbon Dioxide; Female; Heart Failure; Humans; Hydrogen-Ion Concentration; Ins | 1970 |
Plasma insulin in heart disease.
Topics: Cardiac Surgical Procedures; Heart Diseases; Heart Failure; Humans; Insulin; Insulin Secretion; Isop | 1971 |